Interim analysis in clinical trials: caution against premature conclusions—the SWOG multiple myeloma S0777 case study
Interim monitoring for efficacy and futility provides critical decision-making boundaries on early termination of randomized clinical trials. Such analyses can accelerate access to effective therapies and limit exposure to ineffective ones, but this must be weighed against premature closure that can risk obscuring a tr...